作者
Arjun Nambiar,Salvador Arlandis,Kari Bø,Hanny Cobussen‐Boekhorst,Elisabetta Costantini,Monica de Heide,Fawzy Farag,Jan Groen,Markos Karavitakis,Marie Carmela Lapitan,Margarida Manso,Serenella Monagas Arteaga,A. Nic An Riogh,Eabhann O’Connor,Muhammad Imran Omar,B. Peyronnet,Véronique Phé,Vasileios Sakalis,Néha Sihra,Lazaros Tzelves,Mary-Lynne van Poelgeest-Pomfret,Tine W.L. van den Bos,C. H. van der Vaart,Chris Harding
摘要
Context: Female lower urinary tract symptoms (FLUTS) are a common presentation in urological practice.Thus far, only a limited number of conditions within female LUTS have been included in the EAU guidelines compendium.The new non-neurogenic female LUTS guideline expands the remit of the guidelines to include these symptoms and conditions.Objective: This review articles summarises the diagnostic section of the non-neurogenic female LUTS guideline, as well as the management of female overactive bladder (OAB), stress urinary incontinence (SUI) and mixed urinary incontinence (MUI).Evidence Acquisition: New literature searches were carried out, dated September 2021, and evidence synthesis conducted using modified GRADE criteria as outlined for all EAU guidelines.A new systematic review (SR)on OAB was carried out by the panel for purposes of this guideline.Evidence Synthesis: The important considerations for informing guideline recommendations have been presented, along with a summary of all the guideline recommendations.Conclusions: Non-neurogenic female LUTS are an important cause of urological dysfunction.The initial evaluation, diagnosis and management should be carried out in a structured and logical fashion based on best available evidence.This guideline serves to present this evidence to health care providers (HCP's) in an easily accessible and digestible format.Patient Summary: In this report we summarise the main recommendations from the EAU nonneurogenic female LUTS guideline, which relates to symptoms and diseases of the female lower urinary tract (bladder and urethra).We cover recommendations related to diagnosis of these conditions, as well as the treatment of overactive bladder, stress urinary incontinence and mixed urinary incontinence.